The New Zealand Herald

NZ’s bowel screening programme quality tool in fight to save lives

- Stephen Halloran Professor Stephen Halloran is based in England where he developed and directed the NHS bowel cancer screening programme from its inception in 2006 until his retirement in 2015. He is an adviser to New Zealand’s national bowel screening pr

New Zealand’s bowel screening programme is worth celebratin­g. As someone who specialise­s in screening for colorectal cancer, I think it is tremendous that your country has made the decision to implement a national bowel screening programme, and that this is now getting under way.

New Zealand’s bowel cancer rates are some of the worst in the world, with around 1200 men and women dying from it every year.

In the lead up to New Zealand launching its bowel screening programme and over the past week, I’ve been surprised to read some of the comments being made. These include suggestion­s that the programme is somehow not up to scratch, and anger that the starting age is not lower.

Setting up a population-based screening programme is no mean feat. Real care must be taken to balance the benefits and risks, for participan­ts and for those requiring access to the same health services who are outside the screening programme.

I have seen many national bowel cancer screening programmes that have been implemente­d on a wave of enthusiasm, media euphoria and political capital. If they have not been planned carefully, with realistic assessment of current resources or quality, if they have not been piloted thoroughly to fully understand the nuances of effective organisati­on, clinical provision and likely outcome, then, with very few exceptions they hit the rocks.

Perhaps the most important element of a bowel cancer programme is to ensure that the referral rate to further investigat­ion (usually colonoscop­y) matches the available resource, a resource which is of high quality, monitored carefully giving proof of that quality. This is what your country is doing.

New Zealand is starting with a population at higher risk than most others and with a limited, but growing, colonoscop­y resource. It is therefore imperative to commence screening with an age group that carries the highest risk — in this case those aged 60 to 74 — and it is also rational to roll the programme out gradually as you receive evidence that service provision in individual areas meets specified quality standards.

Your programme has the hallmark of quality, thorough research, detailed planning, meticulous preparatio­n and a focus on ease of access and equity for the population at most risk.

Well-designed programmes, like New Zealand’s, can grow in time to make the most of growing healthcare capacity.

Celebrate your bowel screening programme, and even more importantl­y, when you get sent your screening kit, do the test.

This is a cancer that, in the majority of cases, can be successful­ly treated when detected at an early stage.

There is no argument about the fact that bowel screening saves lives.

Bowel screening is for people who don’t have symptoms of bowel cancer. If you develop any symptoms of bowel cancer, it is important that you talk to your doctor. Informatio­n on the National Bowel Screening Programme is available at bowelscree­ning.health.govt.nz.

Newspapers in English

Newspapers from New Zealand